P

Inventor

MECHOULAM RAPHAEL

IL44 patents
⚠️ This page may combine multiple inventors who share the name “MECHOULAM RAPHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YISSUM RES DEV CO

23 patents
US5538993AJul 23, 1996

Certain tetrahydrocannabinol-7-oic acid derivatives

YISSUM RES DEV CO115 citations96
US5932610AAug 3, 1999

Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals

YISSUM RES DEV CO63 citations95
US5434295AJul 18, 1995

Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds

YISSUM RES DEV CO91 citations95
US5284867AFeb 8, 1994

NMDA-blocking pharmaceutical compositions

YISSUM RES DEV CO57 citations95
US5635530AJun 3, 1997

(3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them

YISSUM RES DEV CO75 citations94
US4876276AOct 24, 1989

(3S-4S)-7-hydroxy-Δ6 -tetrahydrocannabinols

YISSUM RES DEV CO111 citations93
US6331560B1Dec 18, 2001

Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals

YISSUM RES DEV CO21 citations92
US4179517ADec 18, 1979

Novel tetrahydrocannabinol type compounds

YISSUM RES DEV CO64 citations92
US6903137B2Jun 7, 2005

Agonists specific for the peripheral cannabinoid receptor

YISSUM RES DEV CO28 citations90
US6864291B1Mar 8, 2005

Agonists specific for the peripheral cannabinoid receptor

YISSUM RES DEV CO27 citations90
US9447019B2Sep 20, 2016

Fluorinated CBD compounds, compositions and uses thereof

YISSUM RES DEV CO21 citations88
US5618955AApr 8, 1997

Fatty acid derivatives and pharmaceutical compositions containing same

YISSUM RES DEV CO85 citations88
US5605928AFeb 25, 1997

Antiemetic compositions

YISSUM RES DEV CO22 citations86
US9782360B2Oct 10, 2017

Fluorinated CBD compounds, compositions and uses thereof

YISSUM RES DEV CO12 citations80
US7759526B2Jul 20, 2010

Pharmaceutical compositions comprising cannabidiol derivatives

YISSUM RES DEV CO18 citations80
US6566543B2May 20, 2003

2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury

YISSUM RES DEV CO14 citations80
US6545041B2Apr 8, 2003

Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals

YISSUM RES DEV CO8 citations73
US7214716B2May 8, 2007

Agonists specific for the peripheral cannabinoid receptor

YISSUM RES DEV CO7 citations71
US6531636B1Mar 11, 2003

Synthetic endogenous cannabinoids analogues and uses thereof

YISSUM RES DEV CO8 citations67
US7884133B2Feb 8, 2011

Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives

YISSUM RES DEV CO2 citations61
US7749953B2Jul 6, 2010

Methods compositions and articles of manufacture for modulating bone growth

YISSUM RES DEV CO2 citations61
US9365534B2Jun 14, 2016

Arylated camphenes, processes for their preparation and uses thereof

YISSUM RES DEV CO1 citations49
US7407753B2Aug 5, 2008

Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis

YISSUM RES DEV CO0 citations45

MECHOULAM RAPHAEL

6 patents

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD

6 patents

UNIV RAMOT

2 patents

BURSTEIN SUMNER H

1 patent

KENNEDY RHEUMATOLOGY INST

1 patent

WEBSTER G R BARRIE

1 patent

WEISS LOLA

1 patent

BAB ITAI

1 patent

EPM IP INC

1 patent

BERRY ELLIOT

1 patent